Robert Z. Orlowski

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 42 papers. Top paper: “Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma”.

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

New England Journal of Medicine(2022)10.1056/nejmoa2204925

N/A

6.2DataRank · unranked

474 citations

Susanna Jacobus, Edie Weller, Hani Hassoun, Sagar Lonial, Noopur Raje +51 more

Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30354-9

N/A

3.8DataRank · unranked

126 citations

Antje Hoering, Sikander Ailawadhi, Rachael Sexton, Brea Lipe, Sandi Hita +12 more

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

Blood Advances(2020)10.1182/bloodadvances.2019000491

N/A

1.1DataRank · unranked

31 citations

Niels Weinhold, Gregory Song, Kristin A. Rand, David Van Den Berg, Amie E. Hwang +65 more

Acetyl-CoA Synthetase 2: A Critical Linkage in Obesity-Induced Tumorigenesis in Myeloma

Cell Metabolism(2021)10.1016/j.cmet.2020.12.011

N/A

0.705DataRank · unranked

109 citations

Huan Liu, Jin He, Zhiqiang Wang, Zheng Yin, Gichun You +12 more

Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

Blood(2024)10.1182/blood.2024025939

N/A

0.621DataRank · unranked

10 citations

Rachael Sexton, Andrew J. Cowan, Aaron S. Rosenberg, Sikander Ailawadhi, S. Vincent Rajkumar +9 more

Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth

Nature Communications(2024)10.1038/s41467-024-44873-4

N/A

0.571DataRank · unranked

44 citations

Yan Cheng, Visanu Wanchai, Wancheng Guo, David Mery, Hongwei Xu +18 more

Race-Dependent Differences in Risk, Genomics, and Epstein–Barr Virus Exposure in Monoclonal Gammopathies: Results of SWOG S0120

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2119

N/A

0.456DataRank · unranked

8 citations

Rachael Sexton, Antje Hoering, Frits van Rhee, Bart Barlogie, Robert Z. Orlowski +1 more

The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration

UNC Libraries(2020)10.17615/2ywv-e505

N/A

0.409DataRank · unranked

3 citations

Jing Yu, Yelin Jiang, Lin Yang, Zhang, Xingding, Huimin Meng +7 more

Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation

Nature Genetics(2025)10.1038/s41588-025-02235-w

N/A

0.385DataRank · unranked

12 citations

Koichi Saeki, Hiroshi Haeno, Chiraag D. Kapadia, Ken Furudate, Jyoti Nangalia +39 more

CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models

Blood Cancer Discovery(2025)10.1158/2643-3230.bcd-25-0130

N/A

0.279DataRank · unranked

5 citations

Sunil Acharya, Francia Reyes-Silva, Rafet Başar, Nadima Uprety, Luz Yurany Moreno Rueda +24 more

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.023

N/A

0.269DataRank · unranked

5 citations

Leonard C. Alsfeld, Denái R. Milton, Ruby Delgado, Uday Popat, Yago Nieto +21 more

Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.11.039

N/A

0.104DataRank · unranked

1 citations

Chelsea C. Pinnix, Susan Wu, Hans C. Lee, Krina K. Patel, Neeraj Saini +9 more

Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma

UNC Libraries(2020)10.17615/tpk1-js83

N/A

0DataRank · unranked

0 citations

Deborah J. Kuhn, Robert Z. Orlowski, Valeria Magarotto, Mark Cornfeld, Michael Wang +8 more

Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia

Neoplasia(2021)10.1016/j.neo.2021.02.002

N/A

0DataRank · unranked

29 citations

Vasantha Lakshmi Gali, Zijun Y. Xu‐Monette, Dahlia Sano, Sheeba K. Thomas, Donna M. Weber +10 more

Genetic determinants of multiple myeloma risk within the Wnt/beta-catenin signaling pathway

Cancer Epidemiology(2021)10.1016/j.canep.2021.101972

N/A

0DataRank · unranked

2 citations

Xifeng Wu, Rashida Callender, Rosalie Waller, Robert Z. Orlowski, Celine M. Vachon +4 more

Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial

Supportive Care in Cancer(2021)10.1007/s00520-021-06110-2

N/A

0DataRank · unranked

5 citations

Qiuling Shi, Tito R. Mendoza, Araceli García-González, Ting‐Yu Chen, Mona Kamal +5 more

Changes in Field Termination of Resuscitation and Survival Rates After an Educational Intervention to Promote on Scene Resuscitation for Out-of-Hospital Cardiac Arrest

Journal of Emergency Medicine(2021)10.1016/j.jemermed.2020.10.003

N/A

0DataRank · unranked

4 citations

Johanna C. Innes, Michael R. Waldrop, Lynn J. White, Eric Dievendorf, Robert Z. Orlowski +5 more

Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms

International Journal of Molecular Sciences(2022)10.3390/ijms232113427

N/A

0DataRank · unranked

7 citations

Kate Rappard, Stephanie N. Shishido, Sonia Maryam Setayesh, Guilin Tang, Pei Lin +13 more

Randomized phase II trial of bortezomib, lenalidomide, dexamthasone with/without elotuzumab for newly diagnosed, high risk multiple myeloma (SWOG-1211).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8054

N/A

0DataRank · unranked

4 citations

Antje Hoering, Sikander Ailawadhi, Rachael Sexton, Brea Lipe, Jason Valent +11 more

Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease

Cancer Cell(2023)10.1016/j.ccell.2023.05.007

N/A

0DataRank · unranked

49 citations

Guangchun Han, Hans C. Lee, Krina K. Patel, Melody Becnel, Linghua Wang +24 more

Data from Inhibition of Interleukin-6 Signaling with CNTO 328 Enhances the Activity of Bortezomib in Preclinical Models of Multiple Myeloma

(2023)10.1158/1078-0432.c.6516807.v1

N/A

0DataRank · unranked

0 citations

Qing Chen, Deborah J. Kuhn, George W. Small, Sally A. Hunsucker, John S. Strader +5 more

Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.06.001

N/A

0DataRank · unranked

8 citations

Curtis Marcoux, Jianliang Dai, Denái R. Milton, Mark R. Tanner, Naureen Syed +18 more

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

UNC Libraries(2024)10.17615/ct6n-5k64

N/A

0DataRank · unranked

0 citations

David V. Conti, J Mehta, Thomas G. Martin, Kenneth C. Anderson, Song, G.C. +65 more

Clonal Origin of Therapy-Related Myeloid Neoplasms after Autologous Stem Cell Transplant

Blood(2024)10.1182/blood-2024-208106

N/A

0DataRank · unranked

0 citations

Koichi Saeki, Hiroshi Haeno, Chiraag D. Kapadia, Ken Furudate, Jyoti Nangalia +35 more

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

Journal of Clinical Oncology(2025)10.1200/jco-24-01893

N/A

0DataRank · unranked

142 citations

Faith E. Davies, Mehmet Samur, Jill Corre, Mattia D’Agostino, Martin Kaiser +41 more

Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel

Blood Advances(2025)10.1182/bloodadvances.2024014476

N/A

0DataRank · unranked

10 citations

Lubna Rehman, Abdur Rehman, Faezeh Darbaniyan, Donna M. Weber, Melody Becnel +21 more

Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)

Blood Cancer Journal(2020)10.1038/s41408-020-0311-8

N/A

0DataRank · unranked

252 citations

Antje Hoering, Rachael Sexton, Muneer H. Abidi, Joshua Epstein, S. Vincent Rajkumar +8 more

Targeting caseinolytic mitochondrial matrix peptidase, a novel contributor to the pathobiology of high-risk multiple myeloma

Blood(2025)10.1182/blood.2024024781

N/A

0DataRank · unranked

6 citations

Luz Yurany Moreno Rueda, Upasana Ray, Iqbal Mahmud, Lin Tan, Philip L. Lorenzi +15 more

Randomized, multi-center study of carfilzomib, lenalidomide, and dexamethasone (KRd) with or without daratumumab (D) in patients with newly diagnosed multiple myeloma (NDMM): The ADVANCE clinical trial.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.7503

N/A

0DataRank · unranked

10 citations

Jing Christine Ye, Jens Hillengaß, Douglas W. Sborov, James E. Hoffman, Benjamin Diamond +15 more

Characterizing circulating rare cells in peripheral blood for detecting and monitoring multiple myeloma and precursor states

npj Precision Oncology(2025)10.1038/s41698-025-01175-2

N/A

0DataRank · unranked

0 citations

J. F. A. MASON, Mohamed Kamal, Sonia Maryam Setayesh, Amishi U. Vora, David Berrios +6 more

Single-cell proteomic analysis reveals Multiple Myeloma heterogeneity and the dynamics of the tumor immune microenvironment in precursor and advanced states

Neoplasia(2025)10.1016/j.neo.2025.101189

N/A

0DataRank · unranked

6 citations

Stephanie N. Shishido, Jeremy Mason, Krina K. Patel, Elisabet E. Manasanch, Robert Z. Orlowski +2 more

Intravenous Immunoglobulin G Suppresses Heat Shock Protein (HSP)-70 Expression and Enhances the Activity of HSP90 and Proteasome Inhibitors

Frontiers in Immunology(2020)10.3389/fimmu.2020.01816

N/A

0DataRank · unranked

9 citations

Ramesh Singh, Fazal Shirazi, Jie Wan, Hua Wang, Xiaobin Wang +6 more

New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity

Haematologica(2020)10.3324/haematol.2019.235804

N/A

0DataRank · unranked

18 citations

Behrang Amini, Ethan B. Ludmir, Jillian R. Gunther, Sarah A. Milgrom, Chelsea C. Pinnix +15 more

Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma

Supportive Care in Cancer(2020)10.1007/s00520-020-05493-y

N/A

0DataRank · unranked

28 citations

Xin Shelley Wang, Qiuling Shi, Teresa Zyczynski, Catherine Davis, Loretta A. Williams +5 more

Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) for initial therapy of newly diagnosed multiple myeloma (NDMM): Results of ENDURANCE (E1A11) phase III trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.18_suppl.lba3

N/A

0DataRank · unranked

31 citations

Susanna Jacobus, Adam D. Cohen, Matthias Weiss, Natalie S. Callander, Avina A. Singh +15 more

Primary analysis of the randomized phase II trial of bortezomib, lenalidomide, dexamthasone with/without elotuzumab for newly diagnosed, high-risk multiple myeloma (SWOG-1211).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8507

N/A

0DataRank · unranked

26 citations

Sikander Ailawadhi, Rachael Sexton, Antje Hoering, Brea Lipe, Sandi Hita +9 more

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci

UNC Libraries(2020)10.17615/hhzp-hr83

N/A

0DataRank · unranked

0 citations

Elad Ziv, Wendy Cozen, Andrew F. Olshan, Nathaniel Rothman, Thomas G. Martin +95 more

A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors

UNC Libraries(2020)10.17615/gmbp-hs07

N/A

0DataRank · unranked

0 citations

Celeste Lindley, Frances A. Collichio, Lisa A. Carey, Bert H. O’Neil, E. Claire Dees +5 more

Phase II Study of Bortezomib and Pegylated Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer

UNC Libraries(2020)10.17615/wwde-9r73

N/A

0DataRank · unranked

0 citations

Frances A. Collichio, Philip S. Bernard, Robert Z. Orlowski, Inge J. Stijleman, Anastasia Ivanova +5 more

A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma

UNC Libraries(2020)10.17615/tmgg-w910

N/A

0DataRank · unranked

0 citations

Suzanne Lentzsch, Pieter Sonneveld, Sonja Zweegman, Hong Xie, Xiang Qin +13 more

Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study

UNC Libraries(2020)10.17615/q2fj-2t55

N/A

0DataRank · unranked

0 citations

Flora Mulkey, Robert Z. Orlowski, Ben L. Sanford, Richard A. Larson, Susan M. Geyer +5 more

Targeted inhibition of interleukin-6 with CNTO 328 sensitizes pre-clinical models of multiple myeloma to dexamethasone-mediated cell death

UNC Libraries(2020)10.17615/f9gy-gn57

N/A

0DataRank · unranked

0 citations

Peter M. Voorhees, Robert Z. Orlowski, Deborah J. Kuhn, George W. Small, Jeffrey A. Nemeth +2 more